The comfort of Therapy chairs ZeroG

Clinical Department – Chemotherapy

Therapy chair ZeroG presentation

The Novak-M Therapy chair ZeroG bring a new dimension of comfort to patients treated in Clinical Departments. Patients undergoing many treatments including chemotherapy arrive daily to the hospital. Being ill with cancer means an uncertainty and unpredictability and can cut deeply into one’s life. We cannot imagine the distress, fear and anxiety the patients face. Receiving chemotherapy as part of the treatment in cycles on an outpatient basis can lasts for up to 4-5 hours on average.

Ensure safety and comfort

The aim is to provide patients with an environment where the patient feels safe and comfortable.  Cancer patients face a difficult time in their lives, that is why great care is taken about where and how patients spend their time during chemotherapy.  A part of the ward’s equipment are the Therapy chairs ZeroG, which provide the patients with exceptional comfort.

Benefits of the Therapy chair ZeroG

The therapy chair’s mattress with special triple-layer technology foam, which has an open cell structure, offers full support and prevents the patient from overheating and sweating. The chair is equipped with a hand switch that allows patients to adjust the position that suits them best by themselves. The chair also offers a Zero Gravity position, where the body’s gravitational force is released so that the weight of the body is evenly distributed. This relieves pressure on the muscles and joints and speeds up circulation. The footrest contributes to additional comfort.

Would you like to provide such comfort in your ward?

Noval-M are pleased to be able to add a small part to the healing journey with the equipment they manufacture. Patient’s comfort is in the forethought of the ZeroG Therapy chair.

We have evaluation chairs available if you are interested in experiencing what the Novak-M ZeroG therapy chair can bring to the patients on your ward, contact us either directly through the website or by email.

Comments are closed.